Marshall Wace’s Pulmonx LUNG Stock Holding History

Marshall Wace’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-189,730	Closed	-$491K	–	3179
2025 Q2	$491K	Sell	189,730 -270,212	-59%	-$1.07M	﹤0.01%	2152
2025 Q1	$3.1M	Buy	+459,942	New	+$3.26M	﹤0.01%	1272
2024 Q4	–	Sell	-57,109	Closed	-$473K	–	2827
2024 Q3	$473K	Buy	+57,109	New	+$413K	﹤0.01%	1939
2024 Q2	–	Sell	-123,313	Closed	-$1.14M	–	2774
2024 Q1	$1.14M	Buy	123,313 +38,526	+45%	+$452K	﹤0.01%	1601
2023 Q4	$1.08M	Sell	84,787 -71,099	-46%	-$741K	﹤0.01%	1448
2023 Q3	$1.61M	Buy	+155,886	New	+$1.81M	﹤0.01%	1321
2023 Q2	–	Sell	-117,268	Closed	-$1.31M	–	2750
2023 Q1	$1.31M	Buy	117,268 +84,787	+261%	+$837K	﹤0.01%	1685
2022 Q4	$274K	Buy	+32,481	New	+$309K	﹤0.01%	2594
2022 Q3	–	Sell	-15,341	Closed	-$226K	–	3602
2022 Q2	$226K	Buy	+15,341	New	+$316K	﹤0.01%	3134
2021 Q3	–	Sell	-22,968	Closed	-$1.01M	–	3258
2021 Q2	$1.01M	Buy	+22,968	New	+$1M	﹤0.01%	1795

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Marshall Wace's LUNG Position: Q3 2025 in Review

Marshall Wace sold out of Pulmonx (LUNG) in Q3 2025, closing a stake of 189,730 shares — an estimated $491K sold.

Marshall Wace first reported a position in LUNG in Q2 2021 and held it in 10 quarters. The position peaked at $3.1M in Q1 2025. 107 funds tracked by Wall St. Rank hold LUNG as of Q3 2025.

Marshall Wace reported no remaining Pulmonx position as of Q3 2025 after selling out during the quarter.
Marshall Wace sold 189,730 Pulmonx shares in Q3 2025, an estimated $491K.
Marshall Wace first reported a position in Pulmonx in Q2 2021 and held it in 10 quarters.
Marshall Wace's Pulmonx position peaked at $3.1M in Q1 2025.
107 funds tracked by Wall St. Rank held Pulmonx as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.